Novavax CEO Says Expects Company's Covid-19 Shots To Be Available In The U.S. "Potentially As Early As This Week, Certainly We Would Expect By Next Week"
Portfolio Pulse from Benzinga Newsdesk
Novavax CEO has announced that the company's Covid-19 vaccine could be available in the U.S. as early as this week, and certainly by next week.
October 03, 2023 | 7:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novavax's Covid-19 vaccine could be available in the U.S. market as early as this week, which could potentially boost the company's stock price.
The availability of Novavax's Covid-19 vaccine in the U.S. market could increase the company's revenues and potentially boost its stock price. The news is highly relevant as it directly pertains to the company's product and potential earnings.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100